Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

In a new study, researchers hypothesized and developed broad-spectrum SARS-CoV-2 inhibitors, ReconnAbs, by modifying the existing non-neutralizing antibodies targeted towards the highly conserved epitopes of the SARS-CoV-2 spike (S) protein combined with a receptor-blocking component.

28 Jan 2022

Living human breast milk cells offer insight into breast cancer development

Researchers have explored the cellular changes that occur in human mammary tissue in lactating and non-lactating women, offering insight into the relationship between pregnancy, lactation, and breast cancer.

28 Jan 2022

New simulation model shows how likely the SARS-CoV-2 virus spreads in different school settings

A year ago, the whole world discussed: is it irresponsible to send children to school during a pandemic, or do measures exist that can prevent corona clusters so efficiently that schools can stay open (or reopen)?

28 Jan 2022

Diagnosing COVID-19 with the new isothermal amplification technology

Announcing a new article publication for Zoonoses journal. During the COVID-19 pandemic, polymerase chain reaction (PCR) has become the gold standard for the detection of SARS-CoV-2 RNA worldwide.

28 Jan 2022

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows

In a 38-year-old man who manifested mild symptoms of COVID-19 for 20 days, the novel coronavirus continued to be detected in his organism and to undergo mutations for 232 days.

27 Jan 2022

COVID-19 pandemic may have exacerbated nurses' sleep problems

More than half of nurses had difficulty sleeping during the first six months of the COVID-19 pandemic - and getting less sleep increased their odds of experiencing anxiety and depression, according to a new study led by researchers at NYU Rory Meyers College of Nursing.

27 Jan 2022

Masking young children linked with fewer childcare program closures due to COVID-19

A new Yale study found that child care programs in the United States that practiced child masking early in the COVID-19 pandemic (May-June 2020) experienced a 13% reduction in program closure within the following year, and continued child masking throughout the one-year study period was associated with a 14% reduction in program closure.

27 Jan 2022

KHN’s ‘What the Health?’: Record ACA enrollment puts pressure on Congress

The Biden administration announced that 14.5 million Americans have signed up for health insurance under the Affordable Care Act for 2022.

27 Jan 2022

Targeting CHI3L1 inhibits SARS-CoV-2 variants, including Delta and Omicron

Researchers show that the CHI3L1 inhibitors reduce epithelial cell infection by SARS-CoV-2 VOC pseudovirus moieties.

27 Jan 2022

Cedars-Sinai experts conduct a national analysis on COVID-19 lung transplants

The analysis of more than 3,000 lung transplants in the U.S. between Aug. 1, 2020, and Sept. 30, 2021, showed that during the pandemic, 7% of the nation's lung transplants were performed to treat severe, irreversible lung damage caused by COVID-19. More than half of these patients needed ventilators or extracorporeal membrane oxygenation, or ECMO, before their transplant.

27 Jan 2022

Aceto consolidates acquisition of six manufacturers, strengthening its unique hybrid model that provides major supply chain benefits to customers

Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, today reported it has consolidated and integrated its six manufacturing-related acquisitions to achieve a hybrid manufacturing/distribution model providing key benefits to its customers in high-growth end markets including pharmaceuticals, biopharmaceuticals, vaccines, nutraceuticals, agriculture, cosmetics and specialty chemicals.

27 Jan 2022

French project takes an extra step in the development of nasal vaccine candidate against COVID-19

The development of a protein vaccine candidate for nasal administration has taken another step. Led by the BioMAP research team, from the Infectiology and Public Health (ISP) joint research unit run by INRAE and the Université de Tours, this project, supported by the Ministry of Higher Education, Research and Innovation, and accompanied by the ANRS | Maladies infectieuses émergentes, is moving up a gear.

27 Jan 2022

National identities play a significant and positive role in battling COVID-19 pandemic

Identification with one's nation predicts both greater engagement with public health behaviors, such as masking and social distancing, and support for public health policies, finds an analysis of attitudes across 67 countries.

27 Jan 2022

Strict COVID-19 lockdown policies helped reduce air pollution levels and death rates in Europe

Strict COVID-19 lockdown policies such as workplace closures in European cities reduced levels of air pollution and the number of associated deaths, according to new estimates published in Nature's Scientific Reports.

27 Jan 2022

Targeting SARS-CoV-2 M protein may help ease severity of COVID-19

A new study, published on the medRxiv preprint server, focused on the production of human CD4+ T cell lines (TCLs), reactive to either S or M protein, and analyzed if the S and M structural proteins had intrinsic differences in driving antigen-specific CD4+ T cell responses.

27 Jan 2022

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Death rates from ovarian cancer are predicted to fall by 17% in the UK and by 7% in EU countries in 2022 compared to 2017, according to new research published in the leading cancer journal Annals of Oncology today (Wednesday).

27 Jan 2022

Recipients of inactivated COVID-19 vaccine (CoronaVac) can be successfully boosted with different vaccines

In the recently published study in The Lancet, first-authored by Dr. Sue Ann Costa Clemens from the University of Oxford in the United Kingdom and the University of Siena in Italy, a comprehensive analysis has been pursued on the immunogenicity and safety of both homologous and heterologous boosting after receiving the inactivated vaccine CoronaVac.

26 Jan 2022

Pandemic News and Research

Further Reading

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

Living human breast milk cells offer insight into breast cancer development

New simulation model shows how likely the SARS-CoV-2 virus spreads in different school settings

Diagnosing COVID-19 with the new isothermal amplification technology

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows

COVID-19 pandemic may have exacerbated nurses' sleep problems

Masking young children linked with fewer childcare program closures due to COVID-19

KHN’s ‘What the Health?’: Record ACA enrollment puts pressure on Congress

Targeting CHI3L1 inhibits SARS-CoV-2 variants, including Delta and Omicron

Cedars-Sinai experts conduct a national analysis on COVID-19 lung transplants

Aceto consolidates acquisition of six manufacturers, strengthening its unique hybrid model that provides major supply chain benefits to customers

French project takes an extra step in the development of nasal vaccine candidate against COVID-19

National identities play a significant and positive role in battling COVID-19 pandemic

Strict COVID-19 lockdown policies helped reduce air pollution levels and death rates in Europe

Targeting SARS-CoV-2 M protein may help ease severity of COVID-19

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Recipients of inactivated COVID-19 vaccine (CoronaVac) can be successfully boosted with different vaccines

Urinary proteomic COV50 marker accurately predicts adverse COVID-19 outcomes

Microbiome 'profiling' may help identify people at risk of long COVID

New research on SARS-CoV-2 Omicron and care home residents

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News